Radiation Myelopathy

Keyword(s):  
2013 ◽  
Vol 28 (3) ◽  
pp. 132-135
Author(s):  
Yasemin CIHAN

1973 ◽  
Vol 22 (3) ◽  
pp. 109-122 ◽  
Author(s):  
TETSUYA NAGASE ◽  
YUKIFUSA TANAKA ◽  
TADASHI WADA ◽  
TOKIO FUJIMAKI

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Jing Zhang ◽  
Lian-Bing Li ◽  
Zhu Qiu ◽  
Hong-Bo Ren ◽  
Jia-Yan Wu ◽  
...  

The main aim of the present study was to assess the antioxidative effects of human umbilical cord-derived mesenchymal stromal cells (UC-MSCs) in a rat model of radiation myelopathy. UC-MSCs were isolated from Wharton’s jelly (WJ) of umbilical cords. An irradiated cervical spinal cord rat model (C2-T2 segment) was generated using a60Co irradiator to deliver 30 Gy of radiation. UC-MSCs were injected through the tail vein at 90 days, 97 days, 104 days, and 111 days after-irradiation. Histological damage was examined by cresyl violet/Nissl staining. The activities of two antioxidant enzymes catalase (CAT) and glutathione peroxidase (GPX) in the spinal cord were measured by the biomedical assay. In addition, the levels of vascular endothelial growth factor (VEGF) and angiopoietin-2 (Ang-2) in the spinal cord were determined by ELISA methods. Multiple injections of UC-MSCs through the tail vein ameliorated neuronal damage in the spinal cord, increased the activities of the antioxidant enzymes CAT and GPX, and increased the levels of VEGF and Ang-2 in the spinal cord. Our results suggest that multiple injections of UC-MSCs via the tail vein in the rat model of radiation myelopathy could significantly improve the antioxidative microenvironment in vivo.


2009 ◽  
Vol 22 (4) ◽  
pp. 458-463
Author(s):  
R. Conforti ◽  
G. Tagliatatela ◽  
M. De Cristoforo ◽  
A. Di Costanzo ◽  
A. Scuotto ◽  
...  

Intramedullary metastases are rare, accounting for 0.9–5% of spinal metastases. Radiation myelopathy is considered one of the most distressing complications of radiotherapy. In both cases symptoms are aspecific, and there are no characteristic neuroradiologic findings. We describe a case of single intramedullary metastasis from lung microcytoma in a 55-year-old man with a history of malignancy, treated by radiotherapy five years previously. The patient returned to our observation complaining of pain and paraesthesia in the left C7 area. Spinal MRI and rachicentesis findings were aspecific. Ten days later a new MRI showed that the lesion size had increased, and neoplastic cells were found in CSF. Intramedullary metastases are extremely rare, accounting for 0.1–0.4% of all CNS tumors. The risk of developing delayed radionecrosis varies with the total dose administered. In both cases diagnosis is histological, while contrast-enhanced MRI is highly sensitive and specific in identifying and characterizing the lesion. In case of metastatic lesions the prognosis is unfavorable. Differential diagnosis is important because it has a strong effect on patient management.


1980 ◽  
Vol 53 (626) ◽  
pp. 168-169 ◽  
Author(s):  
Shirley Hornsey ◽  
Ann White
Keyword(s):  

2020 ◽  
Vol 152 ◽  
pp. 49-55
Author(s):  
Kevin Diao ◽  
Juhee Song ◽  
Peter F. Thall ◽  
Gwendolyn J. McGinnis ◽  
David Boyce-Fappiano ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document